Activity value 75china Supplier,Last transaction date:
2026-06-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shandong yakang pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 112 transactions, with a transaction quantity of 65328.65 and a transaction weight of 0.
Hs code
29413000
Product tags
bat,pharmaceutical raw material,doxycycline hcl,r pharm
Product description
PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY DOXYCYCLINE HCL BATCH NO. A202603107 DATE OF MFG. 18.03.2026 DATE OF EXP. 17.03.2030
Expand
Trade date
2026/06/17
B/L No.
——
Suppliers
shandong yakang pharmaceuticals co.ltd.
Buyers
qas international
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
41128.260244
Hs code
29419090
Product tags
pharmaceutical raw material,lincomycin hcl
Product description
LINCOMYCIN HCL (PHARMACEUTICAL RAW MATERIAL)
Expand
qingdaocourtesy by pakistan revenue automation ltd a company own by cbr governament of pakistan20.21%>
shandong yakang pharmaceuticals co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,r pharm,adc.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 959 international trades,
with its main trading regions covering pakistan,vietnam,philippines etc.
The core products include HS29419090,HS29413000,HS29414000 etc,
often transported via qingdao,port shanghai, port qingdaocourtesy by pakistan revenue automation ltd a company own by cbr governament of pakistan etc,
and its main trading partners are eterna pharma pvt ltd.,aamster laboratories,mallard pharmaceutical pvt ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shandong yakang pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.